STOCK TITAN

Sight Sciences (NASDAQ: SGHT) shares preliminary 2025 financial results

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Sight Sciences, Inc. filed a current report to let investors know it has released preliminary, unaudited financial results. On January 13, 2026, the company issued a press release with selected results for the fourth quarter and full year ended December 31, 2025. That press release is included as Exhibit 99.1 to this Form 8-K under the section covering results of operations and financial condition. The company states that this information, including the exhibit, is being furnished rather than filed, which limits how it is treated under securities law and how it may be incorporated into other SEC filings.

Positive

  • None.

Negative

  • None.
Item 2.02 Results of Operations and Financial Condition Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
false000153117700015311772026-01-132026-01-13

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 13, 2026

 

 

Sight Sciences, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-40587

80-0625749

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

4040 Campbell Avenue

Suite 100

 

Menlo Park, California

 

94025

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 877 266-1144

 

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, $0.001 par value per share

 

SGHT

 

The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 


Item 2.02 Results of Operations and Financial Condition

On January 13, 2026, Sight Sciences, Inc. (the “Company”) issued a press release announcing certain preliminary unaudited financial results for the fourth quarter and year ended December 31, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated into this Item 2.02 by reference.

The information provided in this Item 2.02, including Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

 

Exhibit No.

Description

99.1

Press Release dated January 13, 2026

104

Cover Page Interactive Data File, formatted in Inline XBRL.

 

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

Sight Sciences, Inc.

 

 

 

 

Date:

January 13, 2026

By:

/s/ James Rodberg

 

 

 

James Rodberg
Chief Financial Officer
(Principal Financial and Accounting Officer)

 


FAQ

What did Sight Sciences (SGHT) disclose in this Form 8-K?

Sight Sciences, Inc. disclosed that it issued a press release with preliminary unaudited financial results for the fourth quarter and year ended December 31, 2025, and furnished that release as Exhibit 99.1.

Which period do the preliminary results for Sight Sciences (SGHT) cover?

The preliminary unaudited results cover the fourth quarter and the full fiscal year ended December 31, 2025.

When did Sight Sciences (SGHT) release its preliminary 2025 results?

The company issued its press release announcing certain preliminary unaudited financial results on January 13, 2026.

Where can investors find the detailed preliminary financial results for Sight Sciences (SGHT)?

The detailed preliminary unaudited financial results are contained in the press release furnished as Exhibit 99.1 to this Form 8-K.

Is the preliminary financial information from Sight Sciences (SGHT) considered filed with the SEC?

No. The company states that the information in Item 2.02, including Exhibit 99.1, is being furnished and not filed for purposes of Section 18 of the Exchange Act.

What SEC item does Sight Sciences (SGHT) use for this preliminary results disclosure?

The company provides this update under Item 2.02, Results of Operations and Financial Condition of Form 8-K.

Who signed the Sight Sciences (SGHT) Form 8-K for the preliminary results?

The report was signed on behalf of Sight Sciences, Inc. by James Rodberg, Chief Financial Officer and principal financial and accounting officer.